We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clover Kicks Off Phase 1 Trial of COVID-19 Vaccine in Australia
Clover Kicks Off Phase 1 Trial of COVID-19 Vaccine in Australia
Chinese drugmaker Clover Biopharmaceuticals has dosed the first participants in a phase 1 trial of its COVID-19 vaccine candidate, an Australian study that’s also evaluating two adjuvants contributed by its research partners.